NO20110233A1 - Naeringsmiddelsammensetning for a fremme sunn utvikling og vekst - Google Patents

Naeringsmiddelsammensetning for a fremme sunn utvikling og vekst Download PDF

Info

Publication number: NO20110233A1
Authority: NO; Norway
Prior art keywords: composition; nutritional composition; kcal; oligosaccharide; nutritional
Prior art date: 2008-10-24

Application number

NO20110233A

Other languages

English (en)

Norwegian (no)

Inventor

Robert J Mcmahon

Francisco J Rosales

Gyan P Rai

Kristin Morris

Dattatreya Banavara

Dirk Hondmann

Eric Van Tol

Zeina E Jouni

Deborah A Schade

Donald Carey Walker

Original Assignee

Mjn Us Holdings Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-10-24

Filing date

2011-02-10

Publication date

2011-03-30

2011-02-10 Application filed by Mjn Us Holdings Llc filed Critical Mjn Us Holdings Llc

2011-03-30 Publication of NO20110233A1 publication Critical patent/NO20110233A1/no

Links

239000000203 mixture Substances 0.000 title claims abstract description 121
235000013305 food Nutrition 0.000 title description 6
235000016709 nutrition Nutrition 0.000 claims abstract description 62
229920001542 oligosaccharide Polymers 0.000 claims abstract description 47
235000013406 prebiotics Nutrition 0.000 claims abstract description 39
MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 36
150000002482 oligosaccharides Chemical class 0.000 claims abstract description 32
102000004169 proteins and genes Human genes 0.000 claims abstract description 23
108090000623 proteins and genes Proteins 0.000 claims abstract description 23
235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 22
229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 18
150000002632 lipids Chemical class 0.000 claims abstract description 18
235000019197 fats Nutrition 0.000 claims abstract description 14
238000000855 fermentation Methods 0.000 claims abstract description 14
230000004151 fermentation Effects 0.000 claims abstract description 14
235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 claims abstract description 14
230000009286 beneficial effect Effects 0.000 claims abstract description 13
241000894006 Bacteria Species 0.000 claims abstract description 12
235000020256 human milk Nutrition 0.000 claims description 36
YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 32
210000004251 human milk Anatomy 0.000 claims description 32
DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 28
102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 17
108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 17
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 17
235000021342 arachidonic acid Nutrition 0.000 claims description 16
229940114079 arachidonic acid Drugs 0.000 claims description 16
229920001100 Polydextrose Polymers 0.000 claims description 14
235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 14
150000003271 galactooligosaccharides Chemical class 0.000 claims description 14
239000001259 polydextrose Substances 0.000 claims description 14
229940035035 polydextrose Drugs 0.000 claims description 14
235000013856 polydextrose Nutrition 0.000 claims description 14
239000006041 probiotic Substances 0.000 claims description 14
235000018291 probiotics Nutrition 0.000 claims description 14
235000015097 nutrients Nutrition 0.000 claims description 13
230000000529 probiotic effect Effects 0.000 claims description 10
102000046299 Transforming Growth Factor beta1 Human genes 0.000 claims description 3
102000011117 Transforming Growth Factor beta2 Human genes 0.000 claims description 3
101800002279 Transforming growth factor beta-1 Proteins 0.000 claims description 3
101800000304 Transforming growth factor beta-2 Proteins 0.000 claims description 3
210000000936 intestine Anatomy 0.000 abstract description 2
235000013350 formula milk Nutrition 0.000 description 21
235000018102 proteins Nutrition 0.000 description 20
102000007544 Whey Proteins Human genes 0.000 description 18
108010046377 Whey Proteins Proteins 0.000 description 18
235000021391 short chain fatty acids Nutrition 0.000 description 13
150000004666 short chain fatty acids Chemical class 0.000 description 12
241000186000 Bifidobacterium Species 0.000 description 11
239000003921 oil Substances 0.000 description 11
235000019198 oils Nutrition 0.000 description 11
235000021119 whey protein Nutrition 0.000 description 11
210000001035 gastrointestinal tract Anatomy 0.000 description 10
230000020192 tolerance induction in gut-associated lymphoid tissue Effects 0.000 description 10
235000008504 concentrate Nutrition 0.000 description 8
239000012141 concentrate Substances 0.000 description 8
235000020776 essential amino acid Nutrition 0.000 description 8
239000003797 essential amino acid Substances 0.000 description 8
239000000843 powder Substances 0.000 description 8
230000002028 premature Effects 0.000 description 8
108010076119 Caseins Proteins 0.000 description 7
102000011632 Caseins Human genes 0.000 description 7
239000005862 Whey Substances 0.000 description 7
238000000034 method Methods 0.000 description 7
235000013336 milk Nutrition 0.000 description 7
239000008267 milk Substances 0.000 description 7
210000004080 milk Anatomy 0.000 description 7
150000001720 carbohydrates Chemical class 0.000 description 6
235000014633 carbohydrates Nutrition 0.000 description 6
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 6
235000021240 caseins Nutrition 0.000 description 6
210000004027 cell Anatomy 0.000 description 6
230000036541 health Effects 0.000 description 6
229910052500 inorganic mineral Inorganic materials 0.000 description 6
239000011707 mineral Substances 0.000 description 6
235000010755 mineral Nutrition 0.000 description 6
102000014171 Milk Proteins Human genes 0.000 description 5
108010011756 Milk Proteins Proteins 0.000 description 5
239000000427 antigen Substances 0.000 description 5
102000036639 antigens Human genes 0.000 description 5
108091007433 antigens Proteins 0.000 description 5
244000052616 bacterial pathogen Species 0.000 description 5
239000005018 casein Substances 0.000 description 5
235000005911 diet Nutrition 0.000 description 5
210000003608 fece Anatomy 0.000 description 5
244000005709 gut microbiome Species 0.000 description 5
235000021239 milk protein Nutrition 0.000 description 5
235000013343 vitamin Nutrition 0.000 description 5
239000011782 vitamin Substances 0.000 description 5
229940088594 vitamin Drugs 0.000 description 5
229930003231 vitamin Natural products 0.000 description 5
DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 4
GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 4
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
230000000975 bioactive effect Effects 0.000 description 4
210000000481 breast Anatomy 0.000 description 4
210000001072 colon Anatomy 0.000 description 4
KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 4
235000004626 essential fatty acids Nutrition 0.000 description 4
FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 4
229940107187 fructooligosaccharide Drugs 0.000 description 4
230000002496 gastric effect Effects 0.000 description 4
230000000968 intestinal effect Effects 0.000 description 4
JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 4
229960000511 lactulose Drugs 0.000 description 4
PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 4
239000007788 liquid Substances 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
244000005700 microbiome Species 0.000 description 4
239000005720 sucrose Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
241000283690 Bos taurus Species 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
235000010469 Glycine max Nutrition 0.000 description 3
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
229930006000 Sucrose Natural products 0.000 description 3
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
235000019486 Sunflower oil Nutrition 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
230000008901 benefit Effects 0.000 description 3
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
230000037396 body weight Effects 0.000 description 3
230000000112 colonic effect Effects 0.000 description 3
230000037213 diet Effects 0.000 description 3
235000015872 dietary supplement Nutrition 0.000 description 3
230000000694 effects Effects 0.000 description 3
230000007366 host health Effects 0.000 description 3
230000036737 immune function Effects 0.000 description 3
210000004347 intestinal mucosa Anatomy 0.000 description 3
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
244000052769 pathogen Species 0.000 description 3
229920001282 polysaccharide Polymers 0.000 description 3
239000005017 polysaccharide Substances 0.000 description 3
230000035935 pregnancy Effects 0.000 description 3
230000008569 process Effects 0.000 description 3
239000000047 product Substances 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
235000020183 skimmed milk Nutrition 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000002600 sunflower oil Substances 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
206010000060 Abdominal distension Diseases 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 2
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
102000002322 Egg Proteins Human genes 0.000 description 2
108010000912 Egg Proteins Proteins 0.000 description 2
244000068988 Glycine max Species 0.000 description 2
229920001202 Inulin Polymers 0.000 description 2
241000186660 Lactobacillus Species 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 2
MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 2
JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
229910021529 ammonia Inorganic materials 0.000 description 2
PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
230000033228 biological regulation Effects 0.000 description 2
235000014121 butter Nutrition 0.000 description 2
108010033929 calcium caseinate Proteins 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000000470 constituent Substances 0.000 description 2
235000020247 cow milk Nutrition 0.000 description 2
HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 2
230000000378 dietary effect Effects 0.000 description 2
235000021245 dietary protein Nutrition 0.000 description 2
235000019621 digestibility Nutrition 0.000 description 2
230000029087 digestion Effects 0.000 description 2
239000012895 dilution Substances 0.000 description 2
238000010790 dilution Methods 0.000 description 2
XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
235000013345 egg yolk Nutrition 0.000 description 2
210000002969 egg yolk Anatomy 0.000 description 2
235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
229960005135 eicosapentaenoic acid Drugs 0.000 description 2
JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
210000002919 epithelial cell Anatomy 0.000 description 2
238000009472 formulation Methods 0.000 description 2
229930182830 galactose Natural products 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
239000008103 glucose Substances 0.000 description 2
230000007407 health benefit Effects 0.000 description 2
230000028993 immune response Effects 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
230000006698 induction Effects 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
229940029339 inulin Drugs 0.000 description 2
DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 2
239000008101 lactose Substances 0.000 description 2
244000144972 livestock Species 0.000 description 2
210000002540 macrophage Anatomy 0.000 description 2
230000002503 metabolic effect Effects 0.000 description 2
230000035764 nutrition Effects 0.000 description 2
150000004804 polysaccharides Chemical class 0.000 description 2
102000004196 processed proteins & peptides Human genes 0.000 description 2
108090000765 processed proteins & peptides Proteins 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
230000009467 reduction Effects 0.000 description 2
230000004044 response Effects 0.000 description 2
-1 sialyl oligosaccharides Chemical class 0.000 description 2
241000894007 species Species 0.000 description 2
239000000126 substance Substances 0.000 description 2
DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
241001148536 Bacteroides sp. Species 0.000 description 1
241000483634 Bifidobacterium animalis subsp. lactis BB-12 Species 0.000 description 1
241001608472 Bifidobacterium longum Species 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
241001112696 Clostridia Species 0.000 description 1
206010009900 Colitis ulcerative Diseases 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
229920001503 Glucan Polymers 0.000 description 1
229920002488 Hemicellulose Polymers 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
208000022559 Inflammatory bowel disease Diseases 0.000 description 1
241000917009 Lactobacillus rhamnosus GG Species 0.000 description 1
OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
102000001708 Protein Isoforms Human genes 0.000 description 1
108010029485 Protein Isoforms Proteins 0.000 description 1
235000019484 Rapeseed oil Nutrition 0.000 description 1
206010057190 Respiratory tract infections Diseases 0.000 description 1
235000019485 Safflower oil Nutrition 0.000 description 1
241000191940 Staphylococcus Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
230000024932 T cell mediated immunity Effects 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
102000056172 Transforming growth factor beta-3 Human genes 0.000 description 1
108090000097 Transforming growth factor beta-3 Proteins 0.000 description 1
201000006704 Ulcerative Colitis Diseases 0.000 description 1
VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
235000020661 alpha-linolenic acid Nutrition 0.000 description 1
DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
235000008452 baby food Nutrition 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
229940009291 bifidobacterium longum Drugs 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000000828 canola oil Substances 0.000 description 1
235000019519 canola oil Nutrition 0.000 description 1
229940071162 caseinate Drugs 0.000 description 1
229940021722 caseins Drugs 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
235000013351 cheese Nutrition 0.000 description 1
239000003240 coconut oil Substances 0.000 description 1
235000019864 coconut oil Nutrition 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
239000002285 corn oil Substances 0.000 description 1
235000005687 corn oil Nutrition 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
239000002385 cottonseed oil Substances 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
235000018823 dietary intake Nutrition 0.000 description 1
230000001079 digestive effect Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
230000007515 enzymatic degradation Effects 0.000 description 1
235000020774 essential nutrients Nutrition 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
235000008524 evening primrose extract Nutrition 0.000 description 1
239000010475 evening primrose oil Substances 0.000 description 1
229940089020 evening primrose oil Drugs 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
235000021323 fish oil Nutrition 0.000 description 1
229940013317 fish oils Drugs 0.000 description 1
235000020218 follow-on milk formula Nutrition 0.000 description 1
230000006870 function Effects 0.000 description 1
229940098330 gamma linoleic acid Drugs 0.000 description 1
VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
239000000499 gel Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
230000009931 harmful effect Effects 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000004046 hyporesponsiveness Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
229930193965 lacto-N-fucopentaose Natural products 0.000 description 1
229940039696 lactobacillus Drugs 0.000 description 1
229940059406 lactobacillus rhamnosus gg Drugs 0.000 description 1
229960004232 linoleic acid Drugs 0.000 description 1
229960004488 linolenic acid Drugs 0.000 description 1
KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
239000000944 linseed oil Substances 0.000 description 1
235000021388 linseed oil Nutrition 0.000 description 1
235000014666 liquid concentrate Nutrition 0.000 description 1
210000004698 lymphocyte Anatomy 0.000 description 1
235000021073 macronutrients Nutrition 0.000 description 1
239000000463 material Substances 0.000 description 1
235000012054 meals Nutrition 0.000 description 1
229940057917 medium chain triglycerides Drugs 0.000 description 1
102000006240 membrane receptors Human genes 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
244000005706 microflora Species 0.000 description 1
235000021243 milk fat Nutrition 0.000 description 1
239000003607 modifier Substances 0.000 description 1
210000000440 neutrophil Anatomy 0.000 description 1
239000004006 olive oil Substances 0.000 description 1
235000008390 olive oil Nutrition 0.000 description 1
231100000822 oral exposure Toxicity 0.000 description 1
210000000963 osteoblast Anatomy 0.000 description 1
210000002997 osteoclast Anatomy 0.000 description 1
238000010979 pH adjustment Methods 0.000 description 1
239000003346 palm kernel oil Substances 0.000 description 1
235000019865 palm kernel oil Nutrition 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000006072 paste Substances 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
239000010900 piggery waste Substances 0.000 description 1
239000010773 plant oil Substances 0.000 description 1
230000004983 pleiotropic effect Effects 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
230000017363 positive regulation of growth Effects 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
235000019260 propionic acid Nutrition 0.000 description 1
IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
102000005962 receptors Human genes 0.000 description 1
230000004043 responsiveness Effects 0.000 description 1
239000003813 safflower oil Substances 0.000 description 1
235000005713 safflower oil Nutrition 0.000 description 1
238000004088 simulation Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
229940080237 sodium caseinate Drugs 0.000 description 1
239000000243 solution Substances 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
235000012424 soybean oil Nutrition 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
239000008107 starch Substances 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
210000002536 stromal cell Anatomy 0.000 description 1
239000000758 substrate Substances 0.000 description 1
239000013589 supplement Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
239000002699 waste material Substances 0.000 description 1
239000010497 wheat germ oil Substances 0.000 description 1
229920001221 xylan Polymers 0.000 description 1
150000004823 xylans Chemical class 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Immunology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pediatric Medicine (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Obesity (AREA)
Diabetes (AREA)
Hematology (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Dairy Products (AREA)

NO20110233A 2008-10-24 2011-02-10 Naeringsmiddelsammensetning for a fremme sunn utvikling og vekst NO20110233A1 (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US10830308P	2008-10-24	2008-10-24
US11100908P	2008-11-04	2008-11-04
US12/371,100 US8075934B2 (en)	2008-10-24	2009-02-13	Nutritional composition with improved digestibility
US12/463,994 US8287932B2 (en)	2005-06-30	2009-05-11	Nutritional composition to promote healthy development and growth
PCT/US2009/061792 WO2010048481A1 (en)	2008-10-24	2009-10-23	Nutritional composition to promote healthy development and growth

Publications (1)

Publication Number	Publication Date
NO20110233A1 true NO20110233A1 (no)	2011-03-30

Family

ID=42117714

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20110233A NO20110233A1 (no)	2008-10-24	2011-02-10	Naeringsmiddelsammensetning for a fremme sunn utvikling og vekst
NO20110273A NO340945B1 (no)	2008-10-24	2011-02-17	Næringsmessig komplett morsmelkerstatning

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20110273A NO340945B1 (no)	2008-10-24	2011-02-17	Næringsmessig komplett morsmelkerstatning

Country Status (17)

Country	Link
US (3)	US8075934B2 (es)
EP (2)	EP2337558B1 (es)
CN (2)	CN102186463B (es)
BR (2)	BRPI0920670B1 (es)
CA (2)	CA2741554C (es)
CO (2)	CO6351713A2 (es)
CZ (2)	CZ2011207A3 (es)
ES (2)	ES2604319T3 (es)
MX (2)	MX2011003179A (es)
MY (1)	MY150595A (es)
NO (2)	NO20110233A1 (es)
PE (2)	PE20110846A1 (es)
PL (2)	PL2337558T3 (es)
RU (2)	RU2501553C2 (es)
SG (1)	SG10201601290VA (es)
TW (2)	TWI483681B (es)
WO (2)	WO2010048481A1 (es)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2537452C (en) *	2005-03-09	2013-12-24	Abbott Laboratories	Concentrated human milk fortifier liquid
US7572474B2 (en) *	2005-06-01	2009-08-11	Mead Johnson Nutrition Company	Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
US8293264B2 (en) *	2009-05-11	2012-10-23	Mead Johnson Nutrition Company	Nutritional composition to promote healthy development and growth
WO2010134800A1 (en) *	2009-05-19	2010-11-25	N.V. Nutricia	Human milk fortifier with high protein and long chain poly unsaturated fatty acids for improving body adipose tissue distribution
EP2624824A4 (en) *	2010-09-23	2014-03-26	Tata Global Beverages Ltd	Calcium fortifying composition for strength, a hydration supplement, and process for preparing the same
PH12013500798A1 (en) *	2010-11-02	2021-06-02	Abbott Lab	Stable concentrated liquid human milk fortifier
US20120135103A1 (en) *	2010-11-30	2012-05-31	Mead Johnson Nutrition Company	Staged Infant Feeding Regimen To Promote Healthy Development And Growth
WO2012091542A1 (en)	2010-12-28	2012-07-05	N.V. Nutricia	Combination of components for the prevention and treatment of frailty
DE102011012494A1 (de) *	2011-02-25	2012-08-30	Humana Milchunion Eg	Prebiotische Kohlenhydrat-Zusammensetzungen
US20120269929A1 (en) *	2011-04-22	2012-10-25	Hugh Lippman	Fortified Milk-Based Nutritional Compositions
MY171851A (en)	2011-06-20	2019-11-04	Heinz Co Brands H J Llc	Probiotic compositions and methods
GB201112091D0 (en)	2011-07-14	2011-08-31	Gt Biolog Ltd	Bacterial strains isolated from pigs
GB201117313D0 (en)	2011-10-07	2011-11-16	Gt Biolog Ltd	Bacterium for use in medicine
US9474298B2 (en) *	2011-10-11	2016-10-25	Mead Johnson Nutrition Company	Partially hydrolyzed casein-whey nutritional compositions for reducing the onset of allergies
US20130095204A1 (en) *	2011-10-14	2013-04-18	Zeina Jouni	Nutritional phytonutrient compositions
US20140370153A1 (en) *	2011-12-30	2014-12-18	Abbott Laboratories	Concentrated low water activity liquid human milk fortifier including extensively hydrolyzed protein
WO2013116062A1 (en) *	2012-01-30	2013-08-08	Health & Science, LLC	Salt replacement compositions and methods of using same
JP6147009B2 (ja) *	2012-04-02	2017-06-14	日清オイリオグループ株式会社	ゲル状食品
PL2833724T3 (pl) *	2012-04-04	2020-04-30	Société des Produits Nestlé S.A.	Trwałe w warunkach otoczenia zakwaszone produkty pochodzenia mlecznego albo mlecznopodobne oraz sposoby ich wytwarzania
US20130344042A1 (en) *	2012-06-20	2013-12-26	Gretchen Tanbonliong	Dietary management of celiac disease and food allergy
US20140057014A1 (en) *	2012-08-27	2014-02-27	Carol Lynn Berseth	Formula Fortifier
US20140271978A1 (en) *	2013-03-15	2014-09-18	Mead Johnson Nutrition Company	Low-buffer nutritional compositions and uses thereof
PT2988617T (pt)	2013-03-27	2023-11-21	Nutritional Growth Solutions Ltd	Suplemento nutricional para potenciar o crescimento
GB201306536D0 (en)	2013-04-10	2013-05-22	Gt Biolog Ltd	Polypeptide and immune modulation
PT2994150T (pt)	2013-05-10	2019-06-14	Heinz Co Brands H J Llc	Probióticos e métodos de utilização
US9119409B2 (en) *	2013-06-25	2015-09-01	Philip Zorn	Water soluble nutritional supplement for ruminants
US9241923B2 (en) *	2013-07-16	2016-01-26	Mead Johnson Nutrition Company	Methods for promoting neuronal development and/or health
US9609888B2 (en) *	2013-07-31	2017-04-04	Mead Johnson Nutrition Company	Nutritional compositions containing synergistic combination and uses thereof
US20150119322A1 (en) *	2013-07-31	2015-04-30	Mead Johnson Nutrition Company	Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US10709770B2 (en) *	2013-07-31	2020-07-14	Mead Johnson Nutrition Company	Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US20160095339A1 (en) *	2014-10-01	2016-04-07	Mead Johnson Nutrition Company	Nutritional composition for gastrointestinal environment to provide improved microbiome and metabolic profile
SG11201704161YA (en)	2014-11-25	2017-06-29	Abbott Lab	Method of improving visual processing, visual acuity, or both by administering compositions comprising rrr-alpha-tocopherol and carotenoid to infants
CN104489697A (zh) *	2014-12-19	2015-04-08	成都永安制药有限公司	一种含有低聚甘露糖的具有保健功能的代餐粉及其制备方法
SG10202105996WA (en)	2014-12-23	2021-07-29	4D Pharma Res Ltd	Pirin polypeptide and immune modulation
SMT201800048T1 (it)	2014-12-23	2018-03-08	4D Pharma Res Limited	Un ceppo di bacteroides thetaiotaomicron e suo uso nella riduzione dell'infiammazione
AU2016208455A1 (en) *	2015-01-23	2017-06-15	Société des Produits Nestlé S.A.	Nutritional composition useful in the treatment of IBD patients
US10525016B2 (en)	2015-06-03	2020-01-07	Mead Johnson Nutrition Company	Nutritional compositions containing an elevated level of inositol and uses thereof
TW202223083A (zh)	2015-06-15	2022-06-16	英商4D製藥研究有限公司	包含細菌菌株之組合物之用途
MA41010B1 (fr)	2015-06-15	2020-01-31	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
MA41060B1 (fr)	2015-06-15	2019-11-29	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
IL255662B (en)	2015-06-15	2022-08-01	4D Pharma Res Ltd	Compositions comprising bacterial strains
MA42471B1 (fr)	2015-06-15	2019-12-31	4D Pharma Res Ltd	Compositions comprenant des souches bactériennes
GB201520497D0 (en)	2015-11-20	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
PT3209310T (pt)	2015-11-20	2018-04-20	4D Pharma Res Ltd	Composições compreendendo estirpes bacterianas
GB201520638D0 (en)	2015-11-23	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
GB201520631D0 (en)	2015-11-23	2016-01-06	4D Pharma Res Ltd	Compositions comprising bacterial strains
MX2018009421A (es) *	2016-02-03	2018-12-19	Fresenius Kabi Deutschland Gmbh	Formula nutricional de alto contenido de proteinas y de alto contenido calorico que comprende colageno.
GB201612191D0 (en)	2016-07-13	2016-08-24	4D Pharma Plc	Compositions comprising bacterial strains
CN108883139B (zh)	2016-03-04	2022-04-26	4D制药有限公司	包含细菌菌株的组合物
US9855305B2 (en)	2016-03-29	2018-01-02	Companion Therapeutics Llc	Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors
MX2018012527A (es)	2016-04-14	2019-08-21	Chromadex Inc	Uso de ribosido de nicotinamida, ribosido de acido nicotinico, mononucleotido de nicotinamida y derivados de compuestos nicotinoílo en formula para lactantes.
EP3238676B1 (en)	2016-04-29	2019-01-02	The Procter and Gamble Company	Absorbent core with profiled distribution of absorbent material
TWI802545B (zh)	2016-07-13	2023-05-21	英商４Ｄ製藥有限公司	包含細菌菌株之組合物
GB201621123D0 (en)	2016-12-12	2017-01-25	4D Pharma Plc	Compositions comprising bacterial strains
US20180332881A1 (en) *	2017-05-17	2018-11-22	Mead Johnson Nutrition Company	Preterm infant formula containing butyrate and uses thereof
TW201907928A (zh)	2017-05-22	2019-03-01	英商4D製藥研究有限公司	包含細菌品系之組成物
JP6978514B2 (ja)	2017-05-24	2021-12-08	フォーディーファーマリサーチリミテッド4D Pharma Research Limited	細菌株を含む組成物
MD3638271T2 (ro)	2017-06-14	2021-03-31	4D Pharma Res Ltd	Compoziții cuprizând tulpini bacteriene
CA3066561C (en)	2017-06-14	2022-07-19	4D Pharma Research Limited	Compositions comprising a bacterial strain of the genus megasphera and uses thereof
DK3600363T3 (da)	2017-06-14	2021-01-25	4D Pharma Res Ltd	Sammensætninger omfattende bakteriestammer
US11197917B2 (en)	2017-12-01	2021-12-14	ByHeart, Inc.	Formulations for nutritional support in subjects in need thereof
BR112021022447A2 (pt) *	2019-05-15	2021-12-28	Nutricia Nv	Métodos para aumentar a função da barreira intestinal e/ou para a prevenção e/ou o tratamento de ruptura da barreira intestinal, método para o tratamento, a prevenção e/ou o alívio de uma condição associado à exposição a toxinas, fórmula infantil, fórmula de seguimento ou fórmula para criança de primeira infância, trissacarídeos, composições nutricionais, uso do trissacarídeo e usos de uma composição nutricional
US11849747B1 (en)	2019-06-24	2023-12-26	PBM Nutritionals, LLC	Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US12005083B1 (en)	2019-06-24	2024-06-11	PBM Nutritionals, LLC	Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
WO2021034942A1 (en) *	2019-08-19	2021-02-25	Neuroreserve Inc.	Dietary supplements ameliorating dietary inadequacies related to brain health or neurodegenerative diseases, and methods to design same
CN112933104B (zh) *	2021-02-02	2021-12-14	陈玉松	核苷酸的新用途
CN120836753B (zh) *	2025-09-24	2025-12-02	四平君乐宝乳业有限公司	一种用于促进大脑认知发育的组合物及其制备方法和应用

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6115645A (ja) *	1984-07-03	1986-01-23	Meiji Milk Prod Co Ltd	カルシウム強化飲料及びその製造法
US4859488A (en) *	1987-09-15	1989-08-22	Kabushiki Kaisha Yakult Honsha	Liquid food for curing constipation: polydextrose and oligosaccharide
US4906482A (en) *	1986-03-19	1990-03-06	Zemel Michael B	Method of making calcium fortified soy milk and the calcium fortified soy milk
GB8723094D0 (en)	1987-10-01	1987-11-04	Ciba Geigy Ag	Polypeptide growth factor from milk
FI892006L (fi) *	1988-04-29	1989-10-30	Phil Gold	Lactalbumin saosom tillaeggsaemne i mat.
CA1338682C (en)	1988-12-23	1996-10-29	Gustavo Bounous	Biologically active undenatured whey protein concentrate as food supplement
US5795611A (en) *	1989-12-20	1998-08-18	Slattery; Charles W.	Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein
US5407957A (en) *	1990-02-13	1995-04-18	Martek Corporation	Production of docosahexaenoic acid by dinoflagellates
ES2236681T3 (es)	1990-07-13	2005-07-16	Gropep Limited	Agente promotor de crecimiento.
US6319522B1 (en) *	1990-07-13	2001-11-20	Gropep Limited	Growth-promoting agent
ATE200619T1 (de) *	1991-01-24	2001-05-15	Martek Corp	Mikrobielle öle und ihre verwendungen
DE69128283T2 (de) *	1991-08-12	1998-03-19	Nestle Sa	Nahrungsmittelzusammensetzung
US5952034A (en) *	1991-10-12	1999-09-14	The Regents Of The University Of California	Increasing the digestibility of food proteins by thioredoxin reduction
JP2654529B2 (ja) *	1992-03-27	1997-09-17	大塚製薬株式会社	健康飲料組成物
US5397589A (en) *	1992-09-02	1995-03-14	Ohio State University Research Foundation	Preparation of calcium fortified powdered milk products with improved dispersibility
US6395494B1 (en) *	1993-05-13	2002-05-28	Neorx Corporation	Method to determine TGF-β
ATE272947T1 (de) *	1992-10-27	2004-08-15	Fuso Chemical Co Ltd	Bifidobacterium wachstumspromotor
US5374567A (en) *	1993-05-20	1994-12-20	The United States Of America As Represented By The Secretary Of The Navy	Operational amplifier using bipolar junction transistors in silicon-on-sapphire
FR2714574B1 (fr) *	1993-12-31	1996-03-15	Inst Rech Biolog Sa	Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
AUPM534794A0 (en)	1994-04-28	1994-05-19	Gropep Pty Ltd	Modified milk growth factor
TW517059B (en) *	1994-07-25	2003-01-11	Ciba Geigy Ag	New process for the production of biologically active protein
TW440566B (en) *	1994-07-25	2001-06-16	Novartis Ag	Novel process for the production of biologically active dimeric protein
CA2223198A1 (en) *	1997-01-14	1998-07-14	Societe Des Produits Nestle S.A.	Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
EP0852913A1 (en)	1997-01-14	1998-07-15	Societe Des Produits Nestle S.A.	Composition and method for treatment of inflammatory conditions of the gastro-intestinal tract
DE19701382A1 (de) *	1997-01-16	1998-07-23	Nutricia Nv	Kohlenhydratmischung
JP3186630B2 (ja)	1997-02-14	2001-07-11	株式会社デンソー	データ通信方法および車載用通信装置ならびに路上用通信装置
US5840361A (en) *	1997-04-09	1998-11-24	Beech-Nut Nutrition Corporation	Fructan-containing baby food compositions and methods therefor
ATE208205T1 (de) *	1997-07-05	2001-11-15	Nestle Sa	Lactobacilli zur erhöhung der mineralienabsorption durch darmzellen
US6841149B1 (en) *	1998-05-29	2005-01-11	Agri-King, Inc.	Probiotic mixture intended for monogastric animals to control intestinal flora populations
WO1999065335A1 (en) *	1998-06-19	1999-12-23	Beth Israel Deaconess Medical Center	Dietary supplement for individuals under stress
DE19836339B4 (de)	1998-08-11	2011-12-22	N.V. Nutricia	Kohlenhydratmischung
US6866877B2 (en) *	1998-12-29	2005-03-15	Mac Farms, Inc.	Carbonated fortified milk-based beverage and method for suppressing bacterial growth in the beverage
EP1034704A1 (en) *	1999-03-12	2000-09-13	Societe Des Produits Nestle S.A.	Nutritional composition intended for specific gastro-intestinal maturation in premature mammals
US6706287B2 (en) *	2001-05-15	2004-03-16	Kibow Biotech Inc.	Prebiotic and probiotic compositions and methods for their use in gut-based therapies
US20040161422A1 (en) *	1999-04-30	2004-08-19	Natarajan Ranganathan	Nutritional compositions comprising probiotics
AU6232899A (en)	1999-10-06	2001-05-10	Campina Melkunie B.V.	Use of transforming growth factor beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa
CA2387686A1 (en)	1999-10-06	2001-04-12	Campina B.V.	Process for obtaining growth factor preparations (tgf-beta and igf-1) from milk products having low mutual cross-contamination
DE19958985A1 (de) *	1999-12-07	2001-06-13	Nutricia Nv	Oligosaccharidmischung
EP1062873A1 (en) *	1999-12-13	2000-12-27	N.V. Nutricia	Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
US20040121042A1 (en) *	2001-04-25	2004-06-24	Kabushiki Kaisha Yakult Honsha	Fermented foods and process for producing the same
US6630452B2 (en) *	2000-02-17	2003-10-07	Wyeth	Nutritional formulation containing prebiotic substances
HUP0204546A3 (en) *	2000-03-01	2003-10-28	Nestle Sa	Carbohydrate formulation for enhancement of immune response
RU2283665C2 (ru)	2000-12-22	2006-09-20	Сосьете Де Продюи Нестле С.А.	Индуцирование толерантности
ES2283462T3 (es) *	2000-12-27	2007-11-01	N.V. Nutricia	Composicion nutricional con accion fomentadora de la salud conteniendooligosacaridos.
FI109602B (fi) *	2001-01-25	2002-09-13	Valio Oy	Probioottiyhdistelmä
EP1228707A1 (en) *	2001-02-01	2002-08-07	Campina Melkunie B.V.	Use of alpha-lactalbumin as prebiotic agent
EP1243273A1 (en) *	2001-03-22	2002-09-25	Societe Des Produits Nestle S.A.	Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
WO2002083164A2 (en)	2001-04-10	2002-10-24	Societe Des Produits Nestle S.A.	Method and composition for prophylaxis of diabetes
US20030000391A1 (en)	2001-06-12	2003-01-02	Jay Highman	Organic nutritional formula
FR2827290B1 (fr)	2001-07-13	2004-07-09	Pierre Jouan Biotechnologies Sa	Procede d'obtention d'une fraction proteique enrichie en tgf-beta sous forme activee, fraction proteique et applications therapeutiques
FI20020078A7 (fi) *	2002-01-15	2003-07-16	Danisco	Immuunijärjestelmän stimulointi polydextroosilla
FI119429B (fi)	2002-09-17	2008-11-14	Danisco	Hiilihydraattien uusi käyttö ja koostumukset
RU2234933C2 (ru) *	2002-09-19	2004-08-27	Общество с ограниченной ответственностью "ЛЕОВИТ нутрио"	Препарат "предиабетин"
CN1703149A (zh) *	2002-10-11	2005-11-30	惠氏公司	包含共生菌物质的营养性配方制剂
US7138151B2 (en) *	2002-11-22	2006-11-21	Unilab Pharmatech, Ltd.	Calcium-fortified acidic beverages
US20040191294A1 (en)	2003-03-27	2004-09-30	Ramaprasad Talahalli Ravichandra	Health composition
US20040191295A1 (en) *	2003-03-28	2004-09-30	Locniskar Mary Frances	Composition and method for viral inhibition
JP5473190B2 (ja)	2003-10-16	2014-04-16	ネステクソシエテアノニム	化学療法又は放射線療法の副作用に対する栄養組成物
ATE400278T1 (de)	2003-10-24	2008-07-15	Nutricia Nv	Immunmodulierende oligosaccharide
ATE414428T1 (de)	2003-10-24	2008-12-15	Nutricia Nv	Symbiotische zusammensetzung für kleinkinder
US20050158425A1 (en) *	2003-12-04	2005-07-21	Purac Biochem Bv	Thin mouthfeel calcium-fortified beverage containing calcium lactate gluconate citrate
GB2412834A (en) *	2004-04-07	2005-10-12	International Ltd Valid	A ready-to-use nutritional supplement
US7955834B2 (en) *	2004-06-03	2011-06-07	Biogaia Ab	Method for improved breast milk feeding to reduce the risk of allergy
US20060240148A1 (en) *	2005-04-13	2006-10-26	The Dannon Company, Inc.	High-fiber dairy product
US20060233915A1 (en) *	2005-04-15	2006-10-19	Bristol-Myers Squibb Company	Liquid nutritional product to supplement human milk
US7303745B2 (en) *	2005-04-15	2007-12-04	Bristol-Myers Squibb Company	Method for preventing or treating the development of respiratory allergies
US20060280840A1 (en)	2005-05-24	2006-12-14	Robertson Marion G	Universal protein formulation meeting multiple dietary needs for optimal health and enhancing the human immune system
US7572474B2 (en)	2005-06-01	2009-08-11	Mead Johnson Nutrition Company	Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
WO2006132968A1 (en) *	2005-06-06	2006-12-14	Bristol-Myers Squibb Company	Low-phytate infant formulas
PT1940248E (pt)	2005-10-05	2010-01-26	Nestec Sa	Utilização de uma composição nutricional para promoção do crescimento acelerado
US20070166411A1 (en) *	2005-12-16	2007-07-19	Bristol-Myers Squibb Company	Nutritional supplement containing long-chain polyunsaturated fatty acids
US20080095752A1 (en) *	2006-10-20	2008-04-24	Win-Chin Chiang	Method for extending the shelf-life of powdered nutritional formulations which contain viable probiotics
NL1032840C2 (nl)	2006-11-09	2008-05-13	Friesland Brands Bv	Probiotische hydrolysaatvoeding voor kinderen.

2009
- 2009-02-13 US US12/371,100 patent/US8075934B2/en active Active
- 2009-05-11 US US12/464,029 patent/US9386794B2/en active Active
- 2009-05-11 US US12/463,994 patent/US8287932B2/en not_active Expired - Lifetime
- 2009-10-22 TW TW098135794A patent/TWI483681B/zh not_active IP Right Cessation
- 2009-10-22 TW TW098135795A patent/TWI487489B/zh not_active IP Right Cessation
- 2009-10-23 MX MX2011003179A patent/MX2011003179A/es active IP Right Grant
- 2009-10-23 BR BRPI0920670-1A patent/BRPI0920670B1/pt active IP Right Grant
- 2009-10-23 MX MX2011003433A patent/MX342733B/es active IP Right Grant
- 2009-10-23 CZ CZ20110207A patent/CZ2011207A3/cs unknown
- 2009-10-23 CN CN2009801424094A patent/CN102186463B/zh active Active
- 2009-10-23 PL PL09822759T patent/PL2337558T3/pl unknown
- 2009-10-23 RU RU2011120780/15A patent/RU2501553C2/ru not_active IP Right Cessation
- 2009-10-23 PE PE2011000845A patent/PE20110846A1/es not_active Application Discontinuation
- 2009-10-23 SG SG10201601290VA patent/SG10201601290VA/en unknown
- 2009-10-23 CA CA2741554A patent/CA2741554C/en active Active
- 2009-10-23 WO PCT/US2009/061792 patent/WO2010048481A1/en not_active Ceased
- 2009-10-23 PE PE2011000808A patent/PE20110592A1/es not_active Application Discontinuation
- 2009-10-23 EP EP09822759.8A patent/EP2337558B1/en active Active
- 2009-10-23 CN CN200980142391.8A patent/CN102186493B/zh active Active
- 2009-10-23 BR BRPI0920402-4A patent/BRPI0920402A2/pt not_active Application Discontinuation
- 2009-10-23 PL PL09822758T patent/PL2337572T3/pl unknown
- 2009-10-23 MY MYPI20110651 patent/MY150595A/en unknown
- 2009-10-23 WO PCT/US2009/061794 patent/WO2010048483A1/en not_active Ceased
- 2009-10-23 RU RU2011105430/15A patent/RU2508121C2/ru not_active IP Right Cessation
- 2009-10-23 ES ES09822758.0T patent/ES2604319T3/es active Active
- 2009-10-23 CZ CZ20110206A patent/CZ2011206A3/cs unknown
- 2009-10-23 ES ES09822759.8T patent/ES2597527T3/es active Active
- 2009-10-23 CA CA2740299A patent/CA2740299C/en active Active
- 2009-10-23 EP EP09822758.0A patent/EP2337572B1/en active Active
2011
- 2011-02-10 NO NO20110233A patent/NO20110233A1/no not_active Application Discontinuation
- 2011-02-17 NO NO20110273A patent/NO340945B1/no not_active IP Right Cessation
- 2011-03-14 CO CO11030985A patent/CO6351713A2/es not_active Application Discontinuation
- 2011-03-14 CO CO11030989A patent/CO6351747A2/es active IP Right Grant

Also Published As

Publication number	Publication date
BRPI0920670B1 (pt)	2020-10-06
CN102186463B (zh)	2013-11-06
HK1161840A1 (en)	2012-08-10
EP2337558B1 (en)	2016-08-31
CN102186493B (zh)	2014-04-09
BRPI0920670A8 (pt)	2018-03-20
PE20110592A1 (es)	2011-09-23
MX2011003179A (es)	2011-04-21
CN102186493A (zh)	2011-09-14
TWI483681B (zh)	2015-05-11
US20100104696A1 (en)	2010-04-29
EP2337558A1 (en)	2011-06-29
MX2011003433A (es)	2011-04-21
MX342733B (es)	2016-10-11
RU2011105430A (ru)	2012-11-27
NO340945B1 (no)	2017-07-24
US20100104686A1 (en)	2010-04-29
PL2337572T3 (pl)	2017-03-31
CZ2011207A3 (cs)	2011-11-02
RU2508121C2 (ru)	2014-02-27
PL2337558T3 (pl)	2017-02-28
EP2337572B1 (en)	2016-10-12
CZ2011206A3 (cs)	2011-09-07
CO6351747A2 (es)	2011-12-20
EP2337572A1 (en)	2011-06-29
ES2604319T3 (es)	2017-03-06
SG10201601290VA (en)	2016-03-30
TW201028096A (en)	2010-08-01
RU2011120780A (ru)	2012-11-27
BRPI0920402A2 (pt)	2020-12-08
US20100104545A1 (en)	2010-04-29
TW201028104A (en)	2010-08-01
RU2501553C2 (ru)	2013-12-20
HK1161841A1 (en)	2012-08-10
WO2010048481A1 (en)	2010-04-29
WO2010048483A1 (en)	2010-04-29
EP2337572A4 (en)	2012-08-15
CN102186463A (zh)	2011-09-14
CA2740299A1 (en)	2010-04-29
BRPI0920670A2 (pt)	2015-12-29
US9386794B2 (en)	2016-07-12
ES2597527T3 (es)	2017-01-19
MY150595A (en)	2014-01-30
US8075934B2 (en)	2011-12-13
CA2740299C (en)	2017-08-22
TWI487489B (zh)	2015-06-11
PE20110846A1 (es)	2011-12-24
CA2741554C (en)	2017-09-05
US8287932B2 (en)	2012-10-16
CO6351713A2 (es)	2011-12-20
NO20110273A1 (no)	2011-04-28
CA2741554A1 (en)	2010-04-29
EP2337558A4 (en)	2012-08-08

Publication	Publication Date	Title
US8287932B2 (en)	2012-10-16	Nutritional composition to promote healthy development and growth
EP2645883B1 (en)	2016-05-18	Staged infant feeding regimen to promote healthy development and growth
US8293264B2 (en)	2012-10-23	Nutritional composition to promote healthy development and growth
US9439448B2 (en)	2016-09-13	Nutritional composition to promote healthy development and growth
RU2575747C2 (ru)	2016-02-20	Поэтапный режим кормления грудного ребенка в целях содействия здоровому развитию и росту
HK1242139A1 (en)	2018-06-22	Staged infant feeding regimen to promote healthy development and growth
HK1159495B (en)	2017-10-06	Nutritional composition to promote healthy development and growth
HK1189462A (en)	2014-06-13	Staged infant feeding regimen to promote healthy development and growth
HK1161841B (en)	2015-01-16	Nutritional composition to promote healthy development and growth
HK1161840B (en)	2014-07-25	Nutritional composition to promote healthy development and growth

Legal Events

Date	Code	Title	Description
2013-06-10	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: MJN U.S. HOLDINGS LLC, US
2019-12-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application